Because of the introduction of Apoquel and the active ingredient that it contains, oclacitinib, the field of canine dermatology has undergone a paradigm shift. This revolutionary medication, which is distinguished by the fact that it inhibits JAK in a selective manner, has emerged as a game-changer in the pharmaceutical industry. Oclacitinib's success can be attributed to the meticulous...